Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Israel
  4. TEL AVIV STOCK EXCHANGE
  5. Panaxia Labs Israel Ltd
  6. Summary
    PNAX   IL0011043630

PANAXIA LABS ISRAEL LTD

(PNAX)
  Report
 SummaryChartsNewsCompanyFinancials 
Quotes 5-day view   End-of-day quote. End-of-day quote Tel Aviv Stock Exchange
01/23/2022 01/24/2022 01/25/2022 01/26/2022 01/27/2022 Date
0.906 0.854 0.846 0.852 0.849 Last
117322 197516 79164 63442 67202 Volume
-1.09% -5.74% -0.94% +0.71% -0.35% Change
Estimated financial data (e)
More Financials
Company
Panaxia Labs Israel Ltd is an Israel-based company that provides products and services. 
Sector
Business Support Services
Calendar
-
More about the company
All news about PANAXIA LABS ISRAEL LTD
2021Panaxia Labs Israel Ltd Reports Earnings Results for the Third Quarter and Nine Months ..
CI
2021Panaxia Labs Israel Ltd Reports Earnings Results for the Second Quarter Ended June 30, ..
CI
2021Panaxia Labs Israel Ltd. and Neuraxpharm Expands Strategic Collaboration to Poland
CI
2021IM Cannabis Corp.
AQ
2021IMC Holdings Ltd. agreed to acquire Israel's Largest Retail and Online Pharmacy Busines..
CI
2021Panaxia Labs Israel Ltd Provides Revenue Guidance for the First Quarter of 2021
CI
2021Panaxia Labs Israel Ltd Reports Earnings Results for the Fourth Quarter and Year 2020
CI
2021Government of Cyprus Selects Panaxia Labs Israel Ltd. to Supply Premium Oils
CI
2021Neuraxpharm France and Panaxia Labs Select the Participation in A Pilot Program for the..
CI
2020Panaxia Labs Israel Ltd Reports Revenue Results for the Third Quarter and Nine Months o..
CI
2020Panaxia Labs Israel Ltd. and Neuraxpharm to Receive A Marketing Permit for Medical Cann..
CI
2020Panaxia Labs Israel Ltd announced that it has received ILS 17 million in funding
CI
2020Panaxia Labs Israel Ltd Provides Revenue Guidance for the Third Quarter and Nine Months..
CI
2020Panaxia Labs Israel Ltd Reports Financial Results for the Second Quarter and First Half..
CI
2020Canveda Inc. Enters into Production and Distribution Agreement with Panaxia Pharmaceuti..
CI
More news
News in other languages on PANAXIA LABS ISRAEL LTD
2021Panaxia Labs Israel Ltd fournit des prévisions de revenus pour le premier trimestre de ..
2020Panaxia Labs Israel Ltd fournit des prévisions de revenus pour le troisième trimestre e..
2020Panaxia Labs Israel Ltd. fournit des prévisions de revenus préliminaires pour le deuxiè..
More news
Chart PANAXIA LABS ISRAEL LTD
Duration : Period :
Panaxia Labs Israel Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Dadi Segal Chief Executive Officer & Director
Gil Benyamini Chief Financial Officer
Jonathan B. Kolber Chairman
Eran Goldberg Chief Technology Officer
Tamar Hinenzon Meiri Vice President-Operations
Sector and Competitors
1st jan.Capi. (M$)
PANAXIA LABS ISRAEL LTD-9.97%39
CINTAS CORPORATION-12.83%40 073
TELEPERFORMANCE SE-16.43%21 477
BUREAU VERITAS SA-14.80%12 546
INTERTEK GROUP PLC-5.61%11 492
EDENRED SE-7.81%10 400